Category: Funding Opportunities

UVA – 2019 Faculty fellowships for courses in ethics or for integrating ethics into other subjects

Thanks to a generous gift from the Richard D. Donchian Foundation, the Institute for Practical Ethics and Public Life (IPE), directed by Ruth Gaare Bernheim (William Hopson Chair of Information…

Department of Defense – pre-announcement of Bone Marrow Failure Research Program (BMFRP) FY19

This e-mail is to notify the research community of recently released pre-announcement for the Bone Marrow Failure Research Program (BMFRP) managed by the Department of Defense (DOD) office of Congressionally…

Department of Defense – pre-announcement of Parkinson’s Research Program (PRP) FY19

This e-mail is to notify the research community of recently released pre-announcement for the Parkinson’s Research Program (PRP) managed by the Department of Defense (DOD) office of Congressionally Directed Medical…

NIH – Progression Markers for Cognitive Impairment in Parkinson’s Disease Dementia (R01 Clinical Trial Not Allowed)

In 2011, the National Alzheimer's Project Act (NAPA) allocated resources "to prevent and effectively treat Alzheimer's by 2025."  Since then, the National Institute on Aging (NIA) and the National Institute of…

NIH/NIMH – Novel Assays to Address Translational Gaps in Treatment Development (UG3/UH3 Clinical Trial Optional)

The overall goal of this initiative is to identify neurophysiological measures as potential assays for treatment development research. The funding opportunity announcement (FOA) will support efforts to optimize and evaluate…

NIH – Behavioral & Integrative Treatment Development Program (R01, R34 Clinical Trial Optional)

The following description was taken from the R01 version of this FOA. The goal of this Funding Opportunity Announcement (FOA) is to encourage research grant applications on the development and…

NIH – Next Generation Multipurpose Prevention Technologies (NGM) (R01 Clinical Trial Optional)

The objective of this FOA is to support development of novel long-acting, systemic and non-systemic and on-demand and event-driven Multipurpose Prevention Technologies (MPTs) for the purposes of pregnancy and STI…

NIH – Functional Target Validation for Alzheimer’s Disease-Related Dementias (ADRDs) (UG3/UH3 Clinical Trial Not Allowed)

In 2016, NINDS organized a conference on Alzheimer's Disease Related Dementias (ADRDs) which focused on frontotemporal degeneration (FTD), Lewy body dementias (LBD) (including dementia with Lewy bodies (DLB)), Parkinson disease dementia (PDD),…

NIH/NIAID – Emerging Infectious Diseases Research Centers (U01 Clinical Trial Not Allowed)

The purpose of this Funding Opportunity Announcement (FOA) is to establish a coordinated network of Emerging Infectious Disease Research Centers (EIDRCs) in regions around the globe where emerging and re-emerging…

NIH/NIA – Geroscience Approaches to Alzheimer’s Disease (R01, R21 Clinical Trial Not Allowed)

The following description was taken from the R01 version of this FOA. The basic biology of aging affects the functional performance of all organs in the body, including the brain.…